Evaluation of platelet- and leukocyte-derived extracellular vesicles and immune mediators in the post COVID period

Vol 1, 2024 - 305765
Poster
Favorite this paper
How to cite this paper?
Abstract
Introduction: The post-COVID condition (PCC) is defined by the World Health Organization (WHO) as the persistence or emergence of symptoms after SARS-CoV-2 infection. Acute COVID-19 is associated with a hyperinflammatory state, especially in severe cases. However, few studies addressed the profile of plasma extracellular vesicles (EVs) in the post COVID-19 period. This study aimed to evaluate leukocyte- and platelet-derived EVs and immune mediators in individuals with PCC. Methods: A cross-sectional observational study was performed with patients diagnosed with SARS-CoV-2 during 2020-2022 (IRB 59213722.5.0000.5243). Samples were collected during the acute phase and in the post-COVID period and patients were stratified according to PCC diagnose (WHO) and to hospitalization during the acute infection. Blood samples were collected in 3.2% sodium citrate and serum-separating tubes and centrifuged (2,000 xg 10 min 25ºC) to obtain plasma and serum, respectively. Total plasma EVs and leukocyte- and platelet-derived EVs were isolated by differential centrifugation (12,000xg 2 min, 20,0000xg 20 min at 4ºC). EVs were identified by size (100-900 nm – Gigamix) and positivity for Annexin V and anti-human CD45 (leukocyte marker) or CD41 (platelet marker) and quantified by nanoscale flow cytometry (CytoFLEX S, Beckman Coulter). Negative controls during acquisition, solutions of 0.1% Triton-X, Milli-Q water, Isotype, Annexin V buffer and antibody mixture were used. Circulant levels of cytokines, chemokines and growth factors were assessed by a multiplex assay. Results: We included 46 participants (mean age 54±14 years and 69.6% of females), 23 with PCC (50%). In comparison to the acute phase, counts of total and platelet-derived EVs were significantly decreased in the post-COVID period, independently of PCC diagnosis or previous hospitalization (p<0.0001), but leukocyte-derived EVs count were unchanged. Regarding immune mediators, we observed that levels of IL-6, IFN-gamma, IL-1 Ra, IL-13, MCP-1, IL-8 and MIP-1-alpha were also reduced in the post-COVID period compared to the acute phase. Despite that no differences were found when plasma EVs were compared between PCC and non-PCC groups, we found higher levels of IL-1Ra in the PCC group (p<0.0001). In addition, we found that the levels of IL-1Ra and IFN-gamma are correlated to total and platelet EVs in the PCC group. Conclusions: Our results suggest platelet-derived EVs and circulant levels of immune mediators do not remain increased in the post-COVID period, despite the need for hospitalization in the acute phase or the symptoms reported in the post-COVID period.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Multiuser Laboratory for Research Support in Nephrology and Medical Sciences, Universidade Federal Fluminenense, Niteroi, Brazil
  • 2 Department of Pathology, Faculty of Medicine, Universidade Federal Fluminense, Niterói-RJ, Brazil
  • 3 Department of Clinical Medicine, Universidade Federal Fluminense, Niterói-RJ, Brazil
Research Topic
  • Viral, bacterial, parasitic and fungal disease
Keywords
Inflammation
Coronavirus disease
Extracellular vesicles
Post COVID condition